Chang-Shen Lin

18PUBLICATIONS
10CO-AUTHORS
Molecular targetsInnate immunityCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Nov 14, 2023
Heterogeneity of Phase II Enzyme Ligands on Controlling the Progression of Human Gastric Cancer Organoids as Stem Cell Therapy Model.

Deng-Chyang Wu, Chia-Chen Ku, Jia-Bin Pan

|Aug 18, 2023
Jdp2 is a spatiotemporal transcriptional activator of the AhR via the Nrf2 gene battery.

Kenly Wuputra, Ming-Ho Tsai, Kohsuke Kato

|May 13, 2023
ATM Inhibition-Induced ISG15/IFI27/OASL Is Correlated with Immunotherapy Response and Inflamed Immunophenotype.

Chi-Han Huang, Yun-Cian Huang, Jun-Kai Xu

|Apr 13, 2023
Independent Signaling of Hepatoma Derived Growth Factor and Tumor Necrosis Factor-Alpha in Human Gastric Cancer Organoids Infected by Helicobacter pylori.

Kenly Wuputra, Chia-Chen Ku, Jia-Bin Pan

|Jun 24, 2022
Stem Cell Biomarkers and Tumorigenesis in Gastric Cancer.

Kenly Wuputra, Chia-Chen Ku, Jia-Bin Pan

|May 28, 2022
Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application.

Shigeo Saito, Chia-Chen Ku, Kenly Wuputra

Pageof 3

Frequent Collaborators

11 joint publications

Kazunari K Yokoyama

5 joint publications

Chia-Chen Ku

2 joint publications

Yu-Chu Wang

2 joint publications

Ying-Chu Lin